Global Drug Discovery Enzymes Market Research Report 2024

Publication ID:

PB503247114

Publication Date:

March 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Drug Discovery Enzymes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Enzymes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Enzymes.
Report Scope
The Drug Discovery Enzymes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Enzymes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Enzymes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sigma-Aldrich Co. LLC.
Kaneka Corporation
Actelion Pharmaceuticals Ltd
Genesis Biotechnology Group
Suven Life Sciences Limited
Enzo Life Sciences
Merck KGaA
Segment by Type
Active Kinases
Ubiquitin
Methyltransferases
Deacetylases (hdacs)
Phosphodiesterases (pdes)
Others
Segment by Application
Pharmaceutical and Biotechnology Company
Research Institutes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Discovery Enzymes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Discovery Enzymes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Drug Discovery Enzymes Market Overview
1.1 Product Overview and Scope of Drug Discovery Enzymes
1.2 Drug Discovery Enzymes Segment by Type
1.2.1 Global Drug Discovery Enzymes Market Value Comparison by Type (2024-2030)
1.2.2 Active Kinases
1.2.3 Ubiquitin
1.2.4 Methyltransferases
1.2.5 Deacetylases (hdacs)
1.2.6 Phosphodiesterases (pdes)
1.2.7 Others
1.3 Drug Discovery Enzymes Segment by Application
1.3.1 Global Drug Discovery Enzymes Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical and Biotechnology Company
1.3.3 Research Institutes
1.3.4 Others
1.4 Global Drug Discovery Enzymes Market Size Estimates and Forecasts
1.4.1 Global Drug Discovery Enzymes Revenue 2019-2030
1.4.2 Global Drug Discovery Enzymes Sales 2019-2030
1.4.3 Global Drug Discovery Enzymes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Discovery Enzymes Market Competition by Manufacturers
2.1 Global Drug Discovery Enzymes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Discovery Enzymes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Discovery Enzymes Average Price by Manufacturers (2019-2024)
2.4 Global Drug Discovery Enzymes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Discovery Enzymes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Discovery Enzymes, Product Type & Application
2.7 Drug Discovery Enzymes Market Competitive Situation and Trends
2.7.1 Drug Discovery Enzymes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Discovery Enzymes Players Market Share by Revenue
2.7.3 Global Drug Discovery Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Discovery Enzymes Retrospective Market Scenario by Region
3.1 Global Drug Discovery Enzymes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Discovery Enzymes Global Drug Discovery Enzymes Sales by Region: 2019-2030
3.2.1 Global Drug Discovery Enzymes Sales by Region: 2019-2024
3.2.2 Global Drug Discovery Enzymes Sales by Region: 2025-2030
3.3 Global Drug Discovery Enzymes Global Drug Discovery Enzymes Revenue by Region: 2019-2030
3.3.1 Global Drug Discovery Enzymes Revenue by Region: 2019-2024
3.3.2 Global Drug Discovery Enzymes Revenue by Region: 2025-2030
3.4 North America Drug Discovery Enzymes Market Facts & Figures by Country
3.4.1 North America Drug Discovery Enzymes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Discovery Enzymes Sales by Country (2019-2030)
3.4.3 North America Drug Discovery Enzymes Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Discovery Enzymes Market Facts & Figures by Country
3.5.1 Europe Drug Discovery Enzymes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Discovery Enzymes Sales by Country (2019-2030)
3.5.3 Europe Drug Discovery Enzymes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Discovery Enzymes Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Discovery Enzymes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Discovery Enzymes Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Discovery Enzymes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Discovery Enzymes Market Facts & Figures by Country
3.7.1 Latin America Drug Discovery Enzymes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Discovery Enzymes Sales by Country (2019-2030)
3.7.3 Latin America Drug Discovery Enzymes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Discovery Enzymes Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Discovery Enzymes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Discovery Enzymes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Discovery Enzymes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Discovery Enzymes Sales by Type (2019-2030)
4.1.1 Global Drug Discovery Enzymes Sales by Type (2019-2024)
4.1.2 Global Drug Discovery Enzymes Sales by Type (2025-2030)
4.1.3 Global Drug Discovery Enzymes Sales Market Share by Type (2019-2030)
4.2 Global Drug Discovery Enzymes Revenue by Type (2019-2030)
4.2.1 Global Drug Discovery Enzymes Revenue by Type (2019-2024)
4.2.2 Global Drug Discovery Enzymes Revenue by Type (2025-2030)
4.2.3 Global Drug Discovery Enzymes Revenue Market Share by Type (2019-2030)
4.3 Global Drug Discovery Enzymes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Discovery Enzymes Sales by Application (2019-2030)
5.1.1 Global Drug Discovery Enzymes Sales by Application (2019-2024)
5.1.2 Global Drug Discovery Enzymes Sales by Application (2025-2030)
5.1.3 Global Drug Discovery Enzymes Sales Market Share by Application (2019-2030)
5.2 Global Drug Discovery Enzymes Revenue by Application (2019-2030)
5.2.1 Global Drug Discovery Enzymes Revenue by Application (2019-2024)
5.2.2 Global Drug Discovery Enzymes Revenue by Application (2025-2030)
5.2.3 Global Drug Discovery Enzymes Revenue Market Share by Application (2019-2030)
5.3 Global Drug Discovery Enzymes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sigma-Aldrich Co. LLC.
6.1.1 Sigma-Aldrich Co. LLC. Corporation Information
6.1.2 Sigma-Aldrich Co. LLC. Description and Business Overview
6.1.3 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Product Portfolio
6.1.5 Sigma-Aldrich Co. LLC. Recent Developments/Updates
6.2 Kaneka Corporation
6.2.1 Kaneka Corporation Corporation Information
6.2.2 Kaneka Corporation Description and Business Overview
6.2.3 Kaneka Corporation Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kaneka Corporation Drug Discovery Enzymes Product Portfolio
6.2.5 Kaneka Corporation Recent Developments/Updates
6.3 Actelion Pharmaceuticals Ltd
6.3.1 Actelion Pharmaceuticals Ltd Corporation Information
6.3.2 Actelion Pharmaceuticals Ltd Description and Business Overview
6.3.3 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Product Portfolio
6.3.5 Actelion Pharmaceuticals Ltd Recent Developments/Updates
6.4 Genesis Biotechnology Group
6.4.1 Genesis Biotechnology Group Corporation Information
6.4.2 Genesis Biotechnology Group Description and Business Overview
6.4.3 Genesis Biotechnology Group Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genesis Biotechnology Group Drug Discovery Enzymes Product Portfolio
6.4.5 Genesis Biotechnology Group Recent Developments/Updates
6.5 Suven Life Sciences Limited
6.5.1 Suven Life Sciences Limited Corporation Information
6.5.2 Suven Life Sciences Limited Description and Business Overview
6.5.3 Suven Life Sciences Limited Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Suven Life Sciences Limited Drug Discovery Enzymes Product Portfolio
6.5.5 Suven Life Sciences Limited Recent Developments/Updates
6.6 Enzo Life Sciences
6.6.1 Enzo Life Sciences Corporation Information
6.6.2 Enzo Life Sciences Description and Business Overview
6.6.3 Enzo Life Sciences Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Enzo Life Sciences Drug Discovery Enzymes Product Portfolio
6.6.5 Enzo Life Sciences Recent Developments/Updates
6.7 Merck KGaA
6.6.1 Merck KGaA Corporation Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Drug Discovery Enzymes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Drug Discovery Enzymes Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Discovery Enzymes Industry Chain Analysis
7.2 Drug Discovery Enzymes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Discovery Enzymes Production Mode & Process
7.4 Drug Discovery Enzymes Sales and Marketing
7.4.1 Drug Discovery Enzymes Sales Channels
7.4.2 Drug Discovery Enzymes Distributors
7.5 Drug Discovery Enzymes Customers
8 Drug Discovery Enzymes Market Dynamics
8.1 Drug Discovery Enzymes Industry Trends
8.2 Drug Discovery Enzymes Market Drivers
8.3 Drug Discovery Enzymes Market Challenges
8.4 Drug Discovery Enzymes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Sigma-Aldrich Co. LLC.
Kaneka Corporation
Actelion Pharmaceuticals Ltd
Genesis Biotechnology Group
Suven Life Sciences Limited
Enzo Life Sciences
Merck KGaA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂